Vanessa Costa Miranda

437 total citations
11 papers, 298 citations indexed

About

Vanessa Costa Miranda is a scholar working on Molecular Biology, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Vanessa Costa Miranda has authored 11 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Obstetrics and Gynecology. Recurrent topics in Vanessa Costa Miranda's work include Endometrial and Cervical Cancer Treatments (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). Vanessa Costa Miranda is often cited by papers focused on Endometrial and Cervical Cancer Treatments (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). Vanessa Costa Miranda collaborates with scholars based in Brazil and United States. Vanessa Costa Miranda's co-authors include Maria Del Pilar Estevez-Diz, Rachel P. Riechelmann, Jorge Sabbaga, Maria Ignez Braghiroli, Daniela Freitas, Paulo M. Hoff, Mariana Scaranti, Luiza Dib Batista Bugiato Faria, Elias Abdo Filho and Karime Kalil Machado and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuro-Oncology and American Journal of Clinical Oncology.

In The Last Decade

Vanessa Costa Miranda

10 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vanessa Costa Miranda Brazil 6 147 136 74 69 63 11 298
Yuko Shiroyama Japan 11 84 0.6× 103 0.8× 106 1.4× 53 0.8× 50 0.8× 26 307
Laura M S Seeber Netherlands 7 83 0.6× 255 1.9× 76 1.0× 62 0.9× 34 0.5× 7 368
S. Suchetha India 9 55 0.4× 48 0.4× 82 1.1× 71 1.0× 46 0.7× 35 235
Boer Shan China 12 105 0.7× 81 0.6× 149 2.0× 145 2.1× 24 0.4× 36 358
Kanako Inaba Japan 10 77 0.5× 170 1.3× 48 0.6× 37 0.5× 19 0.3× 13 306
Daisuke Shintani Japan 10 82 0.6× 84 0.6× 129 1.7× 77 1.1× 27 0.4× 34 293
Xuan Pei China 8 142 1.0× 120 0.9× 23 0.3× 44 0.6× 23 0.4× 17 311
Shuqi Chi China 11 56 0.4× 191 1.4× 95 1.3× 88 1.3× 28 0.4× 19 346
Steve Deharo United Kingdom 5 176 1.2× 250 1.8× 75 1.0× 16 0.2× 65 1.0× 8 349
Stefanie Schrauwen Belgium 7 97 0.7× 135 1.0× 32 0.4× 49 0.7× 20 0.3× 7 267

Countries citing papers authored by Vanessa Costa Miranda

Since Specialization
Citations

This map shows the geographic impact of Vanessa Costa Miranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Costa Miranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Costa Miranda more than expected).

Fields of papers citing papers by Vanessa Costa Miranda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Costa Miranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Costa Miranda. The network helps show where Vanessa Costa Miranda may publish in the future.

Co-authorship network of co-authors of Vanessa Costa Miranda

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Costa Miranda. A scholar is included among the top collaborators of Vanessa Costa Miranda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Costa Miranda. Vanessa Costa Miranda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Bonadio, Renata Colombo, Vanessa Costa Miranda, Daniela Freitas, et al.. (2019). Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial. Journal of Clinical Oncology. 37(33). 3124–3131. 84 indexed citations
2.
Miranda, Vanessa Costa, et al.. (2018). Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management. Clinics. 73(suppl 1). e450s–e450s. 101 indexed citations
3.
Harada, Guilherme, Vanessa Costa Miranda, Daniela Freitas, et al.. (2018). Adjuvant Carboplatin and Paclitaxel Chemotherapy Followed by Radiotherapy in High-Risk Endometrial Cancer: A Retrospective Analysis. Journal of Global Oncology. 4(4). 1–8. 5 indexed citations
4.
Miranda, Vanessa Costa, Daniela Freitas, Elias Abdo Filho, et al.. (2018). Neoadjuvant chemotherapy with cisplatin and gemcitabine followed by chemoradiation with cisplatin in locally advanced cervical cancer: A phase II, prospective, randomized, trial.. Journal of Clinical Oncology. 36(15_suppl). 5523–5523. 4 indexed citations
5.
Harada, Guilherme, Vanessa Costa Miranda, Patrícia Alves Ferreira, et al.. (2017). Adjuvant carboplatin and paclitaxel chemotherapy followed by radiotherapy in high-risk endometrial cancer: A retrospective analysis.. Journal of Clinical Oncology. 35(15_suppl). e17115–e17115.
6.
Miranda, Vanessa Costa, Maria Ignez Braghiroli, Luiza Dib Batista Bugiato Faria, et al.. (2016). Phase 2 Trial of Metformin Combined With 5-Fluorouracil in Patients With Refractory Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 15(4). 321–328.e1. 60 indexed citations
7.
Miranda, Vanessa Costa, et al.. (2014). Antiepileptic drug prophylaxis in primary brain tumor patients: is current practice in agreement to the consensus?. Journal of Neuro-Oncology. 120(2). 399–403. 13 indexed citations
8.
Miranda, Vanessa Costa, et al.. (2014). Exploring the role of metformin in anticancer treatments: Asystematic review. Drugs of today. 50(9). 623–623. 20 indexed citations
9.
Favero, Giovanni, et al.. (2014). Laparoscopic versus laparotomic cytoreduction in patients with advanced ovarian cancer submitted to NACT: Evaluation of oncologic safety.. Journal of Clinical Oncology. 32(15_suppl). 5589–5589. 1 indexed citations
10.
Miranda, Vanessa Costa, Luiza Dib Batista Bugiato Faria, Maria Ignez Braghiroli, et al.. (2014). A phase II trial of metformin and fluorouracil (MetFU) for patients (pts) with metastatic colorectal cancer (mCRC) refractory to standard treatment.. Journal of Clinical Oncology. 32(3_suppl). 601–601. 8 indexed citations
11.
Saad, Everardo D., Emma Chen Sasse, Vanessa Costa Miranda, et al.. (2012). Formal Statistical Testing and Inference in Randomized Phase II Trials in Medical Oncology. American Journal of Clinical Oncology. 36(2). 143–145. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuko Shiroyama Breakdown of academic impact, for papers by Laura M S Seeber Breakdown of academic impact, for papers by S. Suchetha Breakdown of academic impact, for papers by Boer Shan Breakdown of academic impact, for papers by Kanako Inaba Breakdown of academic impact, for papers by Daisuke Shintani Breakdown of academic impact, for papers by Xuan Pei Breakdown of academic impact, for papers by Shuqi Chi Breakdown of academic impact, for papers by Steve Deharo Breakdown of academic impact, for papers by Stefanie Schrauwen
Rankless by CCL
2026